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a canalith repositioning ma-
neuver (CRM), such as the Ep-
ley or Semont maneuver, should be the 
first-line treatment for benign paroxysmal 
positional vertigo (BPPV) in the elderly 
(strength of recommendation [SOR]: A, 
several good-quality randomized con-
trolled trials [RCTs]). 
Following the Epley maneuver with 
self-treatment at home using a modified 
Epley procedure improves outcomes (SOR: 
B, a single good-quality RCT). Postural re-
strictions aren’t necessary after CRM treat-
ment (SOR: A, several good-quality RCTs).
Medications don’t work as well as a 
CRM, but studies comparing treatments 
are limited (SOR: B, a single good-quality 
RCT). 
EvidEncE-basEd answEr
 What is the best approach to 
benign paroxysmal positional 
vertigo in the elderly?
A
Evidence summary
No epidemiologic data on BPPV in the Unit-
ed States are available, but experts describe 
increasing incidence with advancing age. A 
recent German study found a lifetime preva-
lence of 2.4%, with a cumulative incidence 
approaching 10% by age 80.1 Treatments in-
clude repositioning maneuvers (regimens 
of positioning the patient’s head and body) 
and medication. Evidence about treat-
ing BPPV in elderly patients specifically is 
limited.2-4
These 2 maneuvers work best
Both Epley’s CRM and Semont’s liberatory 
maneuver have been shown to treat BPPV 
effectively. (For descriptions of the maneu-
vers and video links, see “How the Epley and 
Semont maneuvers work” on page 296.)
An RCT with 124 participants (mean age 
58.3 years) demonstrated that either Epley’s or 
Semont’s maneuver decreased the frequency 
of vertigo more than a sham maneuver (P=.021 
and P=.010, respectively).5 Both maneuvers 
were more effective than the Brandt-Daroff 
home exercises (P=.033).5 
Another high-quality, double-blind RCT 
with 67 participants (median age 59 years) re-
ported an improvement in vertigo and nystag-
mus at 24 hours among 80% of patients treated 
with Epley’s CRM, compared with 10% of 
those who received a sham maneuver (P<.001; 
number needed to treat [NNT]=1; 95% confi-
dence interval [CI], 1-2).6 
An RCT that enrolled 80 participants (me-
dian age 64 years) found complete resolution of 
BPPV symptoms and a negative Dix-Hallpike test 
1 week after treatment in 88% of patients who re-
ceived Epley’s CRM plus self-treatment (a modi-
fied Epley’s maneuver) compared with 69% who 
received Epley’s CRM alone (P=.048; NNT=5; 
95% CI, 3-124).7 
Posture restrictions are unnecessary
An RCT involving 50 participants (mean age 
60.9 years) demonstrated that postprocedure 
postural restrictions were unnecessary and 
didn’t improve BPPV remission rates among 
patients receiving CRM (P=.97). No differ-
ences were noted by age or sex.8 Two prospec-
tive nonrandomized studies found that the 
recurrence rate of BPPV symptoms was 15% to 
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Postural 
restrictions 
aren’t necessary 
after a canalith 
repositioning 
maneuver. 
18% at 12 months and 37% to 50% at 40 to 60 
months.9,10 
Drug studies are scarce, but CRM  
appears to work better
Studies of drug treatment among patients with 
BPPV are extremely limited because BPPV as a 
cause of vertigo is often an exclusion criterion 
among medication trials. A small (N=20; age 
range 32-67 years) double-blinded RCT found 
no difference in dizziness symptom scores for 
participants with BPPV who took diazepam 
(5 mg, 3 times daily), lorazepam (1 mg, 3 times 
daily), or placebo (1 capsule, 3 times daily) over 
a period of 4 weeks.11 
An RCT of 156 patients (mean age 74 years) 
with BPPV compared a calcium channel blocker 
(flunarizine, which isn’t available in the United 
States) with Semont’s liberatory maneuver or no 
therapy (observation only). Semont’s maneuver 
was more effective at the 6-month follow-up than 
either the calcium channel blocker or no therapy; 
the rates of asymptomatic patients with a nega-
tive Dix-Hallpike test at follow-up were 94%, 58%, 
and 34%, respectively (P<.001).3 
Although meclizine is often used in clini-
cal practice, only 1 double-blind RCT from 
1972 (N=31, age range 21-77 years) reported 
improvement in symptoms and physical find-
ings for meclizine compared with placebo in 
patients with BPPV.12 
Recommendations 
In a review article, Furman and Cass describe 
the diagnostic maneuver (Dix-Hallpike) and 
How the Epley and semont maneuvers work
ThE EPLEy MAnEuvER
A patient with right-ear BPPV sits on the exam table with her head turned 45° to 
the right, then lies down quickly on the table on a pillow positioned under her 
shoulders. After maintaining this position for 30 seconds, the patient turns her 
head 90° to the left without raising it from the table and waits 30 more seconds. 
The patient then turns her head and body as a unit 90° to the left and waits an-
other 30 seconds before sitting up on the left side of the table.
A patient with left-ear BPPV would perform the maneuver in a similar fash-
ion, but would begin with her head positioned to the left side, eventually rotat-
ing her body to the right side, and end by sitting up on the right side of the exam 
table.
The following link leads to a video showing the modified Epley’s crm for 
treating right-ear, posterior canal BPPV: http://www.neurology.org/content/vol63/
issue1/images/data/150/Dc1/video2.mpg
ThE SEMOnT MAnEuvER
A patient with right-ear BPPV sits on the exam table with her head turned 45° to 
the left, then drops rapidly to the right side so that her head contacts the table 
just behind the right ear. After waiting in this position for 30 seconds, the patient 
moves quickly and smoothly toward the left side (without stopping in the upright 
position) so that the left side of her forehead rests on the exam table. She holds 
this position for 30 seconds, then sits upright again. 
A patient with left-ear BPPV would perform the maneuver in a similar fash-
ion, but begin with her head positioned to the right side.
The following link leads to a video demonstrating Semont’s liberatory maneu-
ver for treating right-ear BPPV: http://www.neurology.org/content/vol63/issue1/
images/data/150/Dc1/video1.mpg
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references
treatment maneuver (Epley) for BPPV.13 They 
recommend using either Epley’s or Semont’s 
maneuver for initial treatment. 
The authors noted that vestibular suppres-
sant medications may decrease the intensity 
of symptoms but don’t reduce the frequency of 
recurrent vertigo attacks. Moreover, medications 
produce unwanted side effects (somnolence, 
lethargy, worsened balance) and may prove 
counterproductive by delaying the central 
nervous system’s adaptation to a peripheral 
vestibular abnormality.                 JFP
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